The global breast lesion localization methods market is experiencing positive growth due to various factors. The market offers several benefits such as increased accuracy and precision in localizing breast lesions, aiding in more targeted and effective surgical interventions. Advanced technologies and techniques, such as wire-guided localization, radioactive seed localization, and magnetic tracers, are improving localization procedures. These methods provide improved patient comfort, reduced procedure time, and better surgical outcomes.
Access Full Report: https://www.databridgemarketresearch.com/reports/global-breast-lesion-localization-methods-market
Data Bridge Market Research analyses that the Breast Lesion Localization Methods Market is expected to grow at a CAGR of 13.0% in the forecast period of 2022 to 2029 and is expected to reach USD 648.66 million by 2029 from USD 244 million in 2021. Governments and healthcare organizations worldwide are actively involved in breast cancer awareness programs, screening campaigns, and research initiatives. Increased funding and support for breast cancer diagnosis and treatment are driving the development and adoption of advanced breast lesion localization methods.
Key Findings of the Study
Shift toward minimally invasive procedures is expected to drive the market's growth rate
The shift towards minimally invasive procedures in breast surgeries is driven by the desire to minimize patient discomfort, reduce scarring, and promote faster recovery. Breast lesion localization methods play a vital role in these procedures by precisely marking the target area for surgical intervention. Accurately localizing the lesion, surgeons can remove or sample the affected tissue while minimizing the impact on healthy surrounding tissue, leading to improved cosmetic outcomes and better preservation of breast function.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Type (Wire Localization, Radioisotope Localization, Radioactive Seed Localization, Radio Occult Lesion Localization, Magnetic Tracers and Others), Biopsy Techniques (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Surgical Biopsy, Incisional Biopsy, Excisional Biopsy, Vacuum-Assisted Breast Biopsy and Others), End User (Diagnostic Centres, Hospitals, Oncology Clinics and Ambulatory Surgical Centres) Usage (Tumor Identification and Sentinel Lymph Node Lumpectomy)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
SOMATEX Medical Technologies GmbH (Germany), BD (Becton, Dickinson and Company) (U.S.), Merit Medical Systems (U.S.), Endomagnetics Ltd (U.K.), Cook Medical (U.S.), Intramedical Imaging, LLC (U.S.), Ranfac Corp. (U.S.), Medtronic (Ireland), Stryker (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (U.S.), Smith+Nephew (U.K.), Boston Scientific Corporation (U.S.), Organogenesis Inc. (U.S.), Arthrex, Inc. (U.S.), Orthofix Medical Inc. (U.S.), Kubtec X-Ray (U.S.), Miltenyi Biotec GmbH (Germany), Naviscan (U.S.), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.) among others
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The breast lesion localization methods market is segmented on the basis of type, biopsy techniques, end user, and usage
- On the basis of type, the breast lesion localization methods market is segmented into wire localization, radioisotope localization, radioactive seed localization, radio occult lesion localization, magnetic tracers, and others. Wire localization dominates the breast lesion localization methods market due to its long-standing use, established techniques, and wide acceptance among surgeons for precise localization of breast lesions prior to surgical procedures with a CAGR of 12% in the forecast period of 2022 to 2029.
In 2022, the wire localization dominates the type segment of the breast lesion localization methods market
In 2022, wire localization dominates the type segment of the breast lesion localization methods market with a CAGR of 12% owing to its widespread acceptance among surgeons, its long history of use, and its proven methods for precisely localizing breast lesions before surgery in the forecast period of 2022-2029.
- 根據切片技術，乳房病灶定位方法市場分為細針抽吸切片、芯針切片、手術切片、切開切片檢查、切除切片檢查、真空輔助乳房切片檢查等。細針抽吸活檢 (FNAB) 因其簡單性、成本效益和準確性而佔據活檢技術市場的主導地位。它涉及使用細針從病變中提取細胞或液體進行細胞學檢查，有助於診斷乳房病變，預測期內複合年增長率為 2022-2029 年為 12.5%。
- 根據最終用戶，乳房病變定位方法市場分為診斷中心、醫院、腫瘤診所和門診手術中心。醫院部門在乳房病變定位方法市場最終用戶部分佔據主導地位，因為醫院擁有完善的醫療設施、先進的成像技術，並且能夠在醫院環境中進行各種外科手術，預測期內（2022 年至 2029 年）的複合年增長率為 12.8%。
2022 年，醫院部門將主導乳房病變定位方法市場的最終用戶部分
2022 年，醫院部門將主導乳房病變定位方法市場的最終用戶部門，這得益於先進成像技術的可及性、綜合的醫療設施以及在醫院環境中進行各種外科手術的能力，預測期內（2022 年至 2029 年）的複合年增長率為 12.8%。
- 根據用途，乳房病灶定位方法市場分為腫瘤辨識和前哨淋巴結腫瘤切除術。腫瘤識別部分在乳房病變定位方法的使用中占主導地位，因為它在準確識別和定位腫瘤、指導外科醫生進行精確的手術幹預以及確保最佳的腫瘤切除和治療結果方面發揮著至關重要的作用。
主要參與者
Data Bridge Market Research 認為以下公司是乳房病變定位方法 市場的主要參與者，它們是 Cook Medical（美國）、Intramedical Imaging, LLC（美國）、Ranfac Corp.（美國）、Medtronic（愛爾蘭）、Stryker（美國）、Wright Medical Group NV（荷蘭）
市場開發
- 2022 年，MOLLI Surgical 和 Sunnybrook Health Sciences Centre 在加拿大各地的醫院推出了 Molli。此次發射有助於更準確地定位腫瘤，從而實現精準手術。
- 2022 年，Merit Medical System 的 Scout Bx 輸送系統獲得了 FDA 批准，這是一種在乳癌手術的立體定位和 MRI 導引活檢中使用的無線乳房定位工具。
- 2021 年，Hologic Inc. 完成對 Somatex Medical Technologies 的收購，這使得 Hologic Inc. 能夠擴大其乳房標記產品線。
- 2020 年，Endomagnetics Ltd. 推出了一款名為 Magseed 的產品。本產品在手術前植入患側乳房，並使用探針向外科醫生精確顯示癌組織的位置。
- 2019 年，庫克的乳房定位和軟組織活檢針產品線被 IZI 收購。因此，IZI 將能夠打入新的市場。
區域分析
從地理上看，乳房病變定位方法市場報告涵蓋的國家有：北美洲的美國、加拿大和墨西哥，歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其，歐洲其他地區，中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓，亞太地區（APAC）的其他地區，沙烏地阿拉伯、阿拉伯聯合大公國、南非、泰國、印尼、菲律賓，亞太地區（APAC）的其他地區，沙烏地阿拉伯、阿聯酋、其他
根據 Data Bridge 市場研究分析：
2022-2029 年預測期內，亞太地區是乳房病變定位方法市場的主導地區
亞太地區在全球乳房病變定位方法市場的主導地位是由多種因素推動的。該地區擁有成熟的企業，並不斷努力改善醫療保健基礎設施。亞太地區各國政府正在增加對乳癌研究的投入，同時大眾對早期檢測重要性的認識也日益增強。此外，主要參與者正關注新興亞洲國家，進一步支持市場成長。這些因素共同促成了亞太地區在乳房病變定位方法市場的領先地位。
有關乳房病變定位方法市場 報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/global-breast-lesion-localization-methods-market
